Bortezomib 3.5mg Injection Egybort

Trade Name: Egybort

Manufacturer: United Biotech Pvt Ltd

Presentation: Injection

Strength: 3.5mg

What is Bortezomib 3.5mg Injection Egybort used for?

Bortezomib 3.5mg Injection Egybort is a drug that is used to treat multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat mantle cell lymphoma patients (fast-growing cancer that begins in the cells of the immune system). Bortezomib belongs to the class of medicines known as antineoplastic agents.

What are the side effects of bortezomib?

The injection site may cause

dizziness,
lightheadedness,
nausea,
vomiting,
lack of appetite,
diarrhoea,
constipation,
weariness,
weakness,
pain/redness.
Nausea,
vomiting and diarrhoea are all common side effects. In some cases, your doctor may prescribe medication to prevent or relieve nausea, vomiting, or diarrhoea.

How is bortezomib given?

Bortezomib powder for solution for injection is given as an intravenous injection twice weekly for two weeks on days 1, 4, 8, and 11 of a 21-day treatment cycle at the recommended dose of 1.3 mg/m2 body surface area. A treatment cycle is defined as a three-week period.

Does bortezomib cause hair loss?

Hair loss is a common occurrence. Hair loss isn’t a direct side effect of Velcade, but it could be caused by other medications you’re taking with it. People using Velcade plus the cytotoxic medication cyclophosphamide, for example, may experience hair loss. (Cytotoxic medications cause cells to die.)

How long can you take bortezomib?

If you’ve already received myeloma treatment, you can have bortezomib on its own. Bortezomib is commonly taken twice a week for two weeks. After that, you get a ten-day rest. A treatment cycle is a three-week period of treatment. To know more click here.

How long is bortezomib in the system?

After a single dose, bortezomib is rapidly transported into tissues, with an initial plasma distribution half-life of less than 10 minutes and a terminal elimination half-life of more than 40 hours.

How many cycles of bortezomib are there?

A therapy cycle is defined as a three-week period. – Between consecutive bortezomib doses, a minimum of 72 hours should pass. – Two further cycles (for a total of eight cycles) are indicated for individuals who had a response at cycle 6.

We are a Global wholesaler and exporter from India and operate in more than 5 countries like Oman, Qatar, UAE, Saudi, Myanmar.  If you’re looking for a different product or brand, click here.